Skip to Content Facebook Feature Image

Sila Appoints Lindsay Caldwell as VP, People

News

Sila Appoints Lindsay Caldwell as VP, People
News

News

Sila Appoints Lindsay Caldwell as VP, People

2025-02-05 23:31 Last Updated At:23:42

ALAMEDA, Calif.--(BUSINESS WIRE)--Feb 5, 2025--

Sila, a next-generation battery materials company, today announced the appointment of Lindsay Caldwell as VP, People. Caldwell is a seasoned executive who has extensive HR expertise from diverse industrial sectors, including biotech, biopharma, and aerospace. Caldwell will assume responsibility for the company’s people strategy and the building of a high-performance, inclusive, and collaborative culture.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205116623/en/

Caldwell’s experience leading teams at a number of companies specializing in manufacturing will support Sila in its rapid scale and industrialization phase, most notably in the ramp-up of Sila’s production capacity at Sila’s Moses Lake facility, the company’s first auto-scale manufacturing plant in Washington state.

“It’s full-steam ahead with our plant construction in Moses Lake and Lindsay’s experience in the industrial segment will bring valuable expertise as we continue to build a diverse team that excels both in technical R&D and manufacturing innovation,” said Gene Berdichevsky, co-founder and CEO of Sila. “Her track record of success and enthusiasm for our mission will ensure we build a performance-driven workforce that can support our ambitious goals.”

Prior to Sila, Caldwell was VP of Human Resources at Metagenomi, an emerging biotechnology company, where she built the HR function from scratch, implemented key programs, helped secure Best Places to Work in the Bay Area awards for three consecutive years, and prepared the company for IPO. She also held strategic HR roles at Gilead Sciences (US and UK), Arup, and Northrop Grumman, supporting the R&D, engineering, and commercial operations functions.

About Sila

Founded in 2011, Sila is a next-generation battery materials company with the mission to power the world’s transition to clean energy. Sila shipped the world’s first commercially available silicon anode for lithium-ion batteries in 2021, and has since enabled battery performance enhancements in millions of consumer electronics devices. Sila’s Titan Silicon will power electric vehicles, including EVs from Mercedes-Benz and will be used within Panasonic Energy’s next-generation lithium-ion batteries. Committed to American leadership in clean energy production, Sila is scaling its technology at its manufacturing facility in Moses Lake, Washington. Major financial investors include 8VC, Bessemer Venture Partners, Canada Pension Plan Investment Board, Coatue, Matrix Partners, Sutter Hill Ventures, and funds and accounts advised by T. Rowe Price Associates, Inc.

Sila announced the appointment of Lindsay Caldwell as VP, People. (Photo: Sila)

Sila announced the appointment of Lindsay Caldwell as VP, People. (Photo: Sila)

WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/

“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”

Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.

In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.

“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.

About ChemWerth, Inc.:

Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.

Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.

Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.

Recommended Articles